These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

729 related items for PubMed ID: 29288338

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The cuprizone model: regional heterogeneity of pathology.
    Wergeland S, Torkildsen Ø, Myhr KM, Mørk SJ, Bø L.
    APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
    [Abstract] [Full Text] [Related]

  • 4. Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.
    Janssen K, Rickert M, Clarner T, Beyer C, Kipp M.
    Mol Neurobiol; 2016 Apr; 53(3):1551-1564. PubMed ID: 25663168
    [Abstract] [Full Text] [Related]

  • 5. Cuprizone-induced demyelination in CNP::GFP transgenic mice.
    Silvestroff L, Bartucci S, Soto E, Gallo V, Pasquini J, Franco P.
    J Comp Neurol; 2010 Jun 15; 518(12):2261-83. PubMed ID: 20437527
    [Abstract] [Full Text] [Related]

  • 6. Regional differences between grey and white matter in cuprizone induced demyelination.
    Gudi V, Moharregh-Khiabani D, Skripuletz T, Koutsoudaki PN, Kotsiari A, Skuljec J, Trebst C, Stangel M.
    Brain Res; 2009 Aug 04; 1283():127-38. PubMed ID: 19524552
    [Abstract] [Full Text] [Related]

  • 7. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.
    Skripuletz T, Hackstette D, Bauer K, Gudi V, Pul R, Voss E, Berger K, Kipp M, Baumgärtner W, Stangel M.
    Brain; 2013 Jan 04; 136(Pt 1):147-67. PubMed ID: 23266461
    [Abstract] [Full Text] [Related]

  • 8. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP, Cui C, Wang Y, Wang J, Troy E, Caggiano AO, Parry TJ, Colburn RW, Pavlopoulos E.
    Neurobiol Dis; 2017 Sep 04; 105():142-155. PubMed ID: 28576706
    [Abstract] [Full Text] [Related]

  • 9. Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.
    Azami Tameh A, Clarner T, Beyer C, Atlasi MA, Hassanzadeh G, Naderian H.
    Ann Anat; 2013 Oct 04; 195(5):415-23. PubMed ID: 23711509
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL/6 mouse model of cuprizone-induced demyelination.
    Yu H, Wu M, Lu G, Cao T, Chen N, Zhang Y, Jiang Z, Fan H, Yao R.
    Brain Res; 2018 Jan 01; 1678():75-84. PubMed ID: 29038005
    [Abstract] [Full Text] [Related]

  • 12. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
    Norkute A, Hieble A, Braun A, Johann S, Clarner T, Baumgartner W, Beyer C, Kipp M.
    J Neurosci Res; 2009 May 01; 87(6):1343-55. PubMed ID: 19021291
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Microglial Neuroinflammation-Independent Reversal of Demyelination of Corpus Callosum by Arsenic in a Cuprizone-Induced Demyelinating Mouse Model.
    Kushwaha S, Saji J, Verma R, Singh V, Ansari JA, Mishra SK, Roy O, Patnaik S, Ghosh D.
    Mol Neurobiol; 2024 Sep 01; 61(9):6822-6841. PubMed ID: 38353925
    [Abstract] [Full Text] [Related]

  • 16. Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation.
    Petković F, Campbell IL, Gonzalez B, Castellano B.
    Glia; 2016 Dec 01; 64(12):2104-2119. PubMed ID: 27535761
    [Abstract] [Full Text] [Related]

  • 17. Cuprizone-induced graded oligodendrocyte vulnerability is regulated by the transcription factor DNA damage-inducible transcript 3.
    Fischbach F, Nedelcu J, Leopold P, Zhan J, Clarner T, Nellessen L, Beißel C, van Heuvel Y, Goswami A, Weis J, Denecke B, Schmitz C, Hochstrasser T, Nyamoya S, Victor M, Beyer C, Kipp M.
    Glia; 2019 Feb 01; 67(2):263-276. PubMed ID: 30511355
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model.
    Iwasa K, Yamamoto S, Takahashi M, Suzuki S, Yagishita S, Awaji T, Maruyama K, Yoshikawa K.
    Prostaglandins Leukot Essent Fatty Acids; 2014 Nov 01; 91(5):175-82. PubMed ID: 25224839
    [Abstract] [Full Text] [Related]

  • 20. Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia.
    Nomura T, Bando Y, You H, Tanaka T, Yoshida S.
    Neurochem Res; 2017 Dec 01; 42(12):3525-3536. PubMed ID: 28929408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.